Avanza Fonder’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$136K Buy
7,505
+1,300
+21% +$23.5K ﹤0.01% 401
2025
Q1
$113K Buy
+6,205
New +$113K ﹤0.01% 431